Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples